Literature DB >> 3168157

Quantitation of protein adducts as a marker of genotoxic exposure: immunologic detection of benzo[a]pyrene--globin adducts in mice.

B M Lee1, R M Santella.   

Abstract

Immunologic methods have been developed for the determination of benzo[a]pyrene (BP)-protein adducts and validated in animals treated with [3H]BP. A previously developed antibody, 8E11, which recognizes 7 beta,8 alpha-dihydroxy-9 alpha,10 alpha-epoxy-7,8,9,10- tetrahydrobenzo[a]pyrene (BPDE-I)-modified DNA or protein as well as BPDE-I-tetraols, was used. The sensitivity of the assay was increased by enzymatic digestion of the modified protein with insoluble protease into peptides and amino acids before analysis. In a competitive enzyme-linked immunosorbent assay (ELISA) with digested BPDE-I-modified bovine serum albumin, 50% inhibition occurred at 400 fmol of adduct compared to 1450 fmol for the non-digested albumin. Analysis of globin (Gb) isolated from animals treated in vivo with 0.3-3 mg [3H]BP indicated that the ELISA could detect 90-100% of the adducts determined by radioactivity. Levels of adducts in lung and liver DNA and serum albumin were correlated with the levels of Gb adducts. Of the total radioactivity associated with hemoglobin, only less than or equal to 10% was from Gb while approximately 80% was from the heme fraction and the remainder from free BP metabolites. Significant cross-reactivity of antibody 8E11 was found with several BP-diols and phenols, suggesting that the immunoassay will not only be specific for BPDE-I adducts but will also detect adducts of other BP metabolites as well as other aromatic hydrocarbon diol epoxides. An immunoaffinity column of antibody 8E11 coupled to Sepharose 4B was used to isolate modified peptides from the digested Gb. About 65% of the applied radioactivity was retained on the column. Between 1 and 2 mg of non-modified digested Gb could be added to the sample without interfering with binding of adducts. Protein digestion and immunoaffinity chromatography should be useful for the measurement of protein adducts in biomonitoring studies.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3168157     DOI: 10.1093/carcin/9.10.1773

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  6 in total

1.  A sandwich enzyme-linked immunosorbent assay for adducts of polycyclic aromatic hydrocarbons with human serum albumin.

Authors:  Ming Kei Chung; Jacques Riby; He Li; Anthony T Iavarone; Evan R Williams; Yuxin Zheng; Stephen M Rappaport
Journal:  Anal Biochem       Date:  2010-01-18       Impact factor: 3.365

2.  Measurement of hemoglobin and albumin adducts of benzo(a)pyrenediolepoxide and their rate of elimination in the female Sprague-Dawley rat.

Authors:  C Viau; M Mercier; O Blondin
Journal:  Arch Toxicol       Date:  1993       Impact factor: 5.153

3.  Determinants of benzo(a)pyrenediol epoxide adducts to haemoglobin in workers exposed to polycyclic aromatic hydrocarbons.

Authors:  M F Ferreira Júnior; S Tas; M dell'Omo; G Goormans; J P Buchet; R Lauwerys
Journal:  Occup Environ Med       Date:  1994-07       Impact factor: 4.402

4.  Benzo(a)pyrenediolepoxide-hemoglobin adducts and 3-hydroxy-benzo(a)pyrene urinary excretion profiles in rats subchronically exposed to benzo(a)pyrene.

Authors:  M Bouchard; C Viau
Journal:  Arch Toxicol       Date:  1995       Impact factor: 5.153

5.  Biomarker studies in northern Bohemia.

Authors:  B Binková; J Lewtas; I Mísková; P Rössner; M Cerná; G Mrácková; K Peterková; J Mumford; S Meyer; R Srám
Journal:  Environ Health Perspect       Date:  1996-05       Impact factor: 9.031

6.  Molecular Mechanism of Tetrabromobisphenol A (TBBPA)-induced Target Organ Toxicity in Sprague-Dawley Male Rats.

Authors:  Jae Seok Choi; Young Jun Lee; Tae Hyung Kim; Hyun Jung Lim; Mee Young Ahn; Seung Jun Kwack; Tae Seok Kang; Kui Lea Park; Jaewon Lee; Nam Deuk Kim; Tae Cheon Jeong; Sang Geum Kim; Hye Gwang Jeong; Byung Mu Lee; Hyung Sik Kim
Journal:  Toxicol Res       Date:  2011-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.